S&P 500 Consumer Staples Sector SEC Filings — April 07, 2026

07-04-2026

The Travelers Companies, Inc. (TRV) filed its DEF 14A Proxy Statement on April 7, 2026, for the Annual Meeting of Shareholders on May 20, 2026, recommending votes FOR electing eight director nominees (7 independent, average age 63, average tenure 6 years, 50% diverse), ratifying KPMG LLP as independent auditors for 2026, approving executive compensation on a non-binding basis, and amending the 2023 Stock Incentive Plan, while recommending AGAINST two shareholder proposals on climate-related reporting and an independent board chairman. Governance highlights include all non-Executive committees comprised of independent directors, an independent Lead Director, regular executive sessions, and non-employee directors receiving over 50% of compensation in deferred stock units. Executive compensation emphasizes pay-for-performance, with CEO mix of 5% base salary, 32% annual cash bonus, and performance-based equity (mix incomplete in filing excerpt).

• ·Annual Meeting: May 20, 2026, 9:00 a.m. EDT at Hartford Marriott Downtown, 200 Columbus Boulevard, Hartford, CT 06103 (virtual option possible).
• ·Record date: March 23, 2026.
• ·Proxy voting deadlines: 11:59 p.m. EDT on May 19, 2026 (record holders/brokers); May 18, 2026 (401(k) plan).
• ·Shareholder proposals: ITEM 5 – Report on Climate-Related Pricing and Coverage Decisions; ITEM 6 – Independent Board Chairman.

07-04-2026

Mattel, Inc. announced that Steve Totzke, President and Chief Commercial Officer, will step down effective May 1, 2026, and transition to Executive Advisor and President, Strategic Transition through December 31, 2026. Sanjay Luthra, Executive Vice President and Managing Director of EMEA and Global Direct-to-Consumer, has been promoted to succeed Totzke as Chief Commercial Officer, reporting to Chairman and CEO Ynon Kreiz. The announcement highlights Totzke's contributions to commercial growth and Luthra's successful leadership in EMEA, ensuring a smooth handover amid a positive outlook on Mattel's brand-centric strategy.

• ·Steve Totzke joined Mattel in 1996, appointed Chief Commercial Officer in 2018, and promoted to President in 2022; served on boards of Toy Association, Mattel Children’s Foundation, and Advisory Board for Women in Toys, Licensing, and Entertainment Association; inducted into Canadian Toy Association Hall of Fame in 2025.
• ·Sanjay Luthra joined Mattel India in 2003, held leadership roles in Eastern Europe and Canada; Chairman of Toy Industries of Europe for past seven years; will be based in El Segundo, California.

07-04-2026

Energy Transition Special Opportunities (formerly Climate Transition Special Opportunities SPAC I) filed an amended S-1/A registration statement on April 7, 2026, for an IPO of Firm Units targeting $150,000,000 in gross proceeds (implied 15 million units at $10 each), with an over-allotment option for up to 2,250,000 additional units. Proceeds from Firm Units and Private Placement will be deposited into a trust account, including a 4.0% deferred underwriting commission of $6,000,000 (up to $900,000 for Option Units). The Sponsor holds 5,750,000 Founder Shares issued for a total of $25,000, with warrants exercisable at $11.50 per share post-Business Combination.

• ·Warrants entitle holder to purchase one Ordinary Share for $11.50, exercisable 30 days after Business Combination, expiring five years after or upon redemption/liquidation
• ·Over-allotment Option exercisable within 45 days of Registration Statement effective date
• ·Company name changed from Climate Transition Special Opportunities SPAC I on September 15, 2025
• ·Founder Shares issued July 30, 2025, with 1-for-1.26605495295 share split on September 4, 2025; 75,000 transferred to director nominees

07-04-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on April 7, 2026, disclosing a press release announcing that its RAD division is implementing its first hardware price increase in nearly three years due to market conditions demanding adjustment. The press release is attached as Exhibit 99.1 and furnished under Item 8.01, not deemed filed or material.

• ·Filing explicitly states information is furnished, not filed, and not deemed material.
• ·Date of earliest event reported: April 7, 2026.

07-04-2026

Velo3D, Inc. appointed James Suva as Chief Financial Officer and principal financial and accounting officer, effective April 6, 2026, as previously disclosed on March 20, 2026. Under the offer letter effective March 5, 2026, Mr. Suva receives an annual base salary of $380,000 and a target bonus for fiscal 2026 equal to 70% of his base salary. The Compensation Committee granted 135,000 RSUs vesting 25% on May 15, 2027, and 1/16th quarterly thereafter subject to continued service.

• ·Offer letter entered April 6, 2026, effective March 5, 2026; at-will employment with customary confidentiality covenants
• ·RSU vesting on Quarterly Vest Dates: February 15, May 15, August 15, November 15
• ·Offer letter filed as Exhibit 10.1

07-04-2026

Cell Source, Inc. (CLCS) 10-K filing highlights severe financial risks, including a history of operating losses, substantial doubt about continuing as a going concern, defaults on promissory notes, and the need for additional financing. The company, an early-stage biotech with an unproven strategy, faces stock-related risks such as illiquid trading, insider voting concentration, dilution from future issuances, and penny stock status. No positive financial or operational metrics are presented, emphasizing ongoing challenges in clinical development and commercialization.

• ·Licensing milestones: Commence Phase 2 clinical trials by January 1, 2028 (with interim research sponsorship); commence Phase 3 or receive FDA/EMA Marketing Approval by January 1, 2031; First Commercial Sale within 12 months of Marketing Approval; no sales for 12+ months post-commencement triggers potential termination.
• ·License terms: Exclusive worldwide license under Licensed Information and Patents until later of last Patent expiration or 15-year period from FDA New Drug Approval; 'Orphan Drug' status extends coverage.
• ·Patent obligations: Company bears costs for infringement litigation and indemnifies Yeda.

07-04-2026

Clayton Street Trust filed DEFA14A soliciting material on April 07, 2026, urging U.S. mutual fund and ETF shareholders to vote FOR a new investment advisory agreement with Janus Henderson, required due to Janus Henderson's take-private transaction with Trian and General Catalyst. The Boards of Trustees recommend approval, emphasizing no changes to investment teams, processes, or portfolio management. Voting is available online at www.votejhi.com/mutualfunds or www.votejhi.com/ETFs, by phone, or by mail.

07-04-2026

On April 7, 2026, Palvella Therapeutics, Inc. (PVLA) posted a corporate presentation to its website, which company representatives will use in meetings with investors from time to time. The presentation is filed as Exhibit 99.1 and incorporated by reference. The filing was signed by Matthew Korenberg, Chief Financial Officer.

07-04-2026

Castellum, Inc. has issued a proxy statement for its 2026 Annual Meeting of Stockholders on May 19, 2026, seeking election of five director nominees (Mark S. Alarie, John F. Campbell, Bernard S. Champoux, Glen R. Ives, and C. Thomas McMillen), ratification of RSM US LLP as independent auditor for the fiscal year ending December 31, 2026, and approval of an amendment to the Second Amended 2021 Stock Incentive Plan to increase shares reserved for issuance to 13,000,000. The record date for stockholders is March 20, 2026. No financial performance metrics or period-over-period comparisons are disclosed in the filing.

• ·Annual Meeting location: Intelligent Office, Tysons, 1934 Old Gallows Road, Room 362, Tysons, VA 22182, at 10:00 a.m. Eastern Time.
• ·Virtual access: live audio webcast via (800) 715-9871 or (646) 307-1963, conference ID 9842123.
• ·Voting methods: Internet (www.proxyvote.com), telephone (1-800-690-6903), mail, or in person; deadline 11:59 p.m. ET on May 18, 2026.
• ·Board committees: Audit (AC), Compensation, Culture, and People (CC), Nominating and Governance (NGC).
• ·Director ages as of March 20, 2026: Mark S. Alarie (62), John F. Campbell (68), Bernard S. Champoux (71), Glen R. Ives (70), C. Thomas McMillen (73).

07-04-2026

Artelo Biosciences filed an S-1 registration statement on April 7, 2026, to register up to 9,820,294 shares for resale by selling stockholders from its March 2026 private placement, which raised gross proceeds of $10,996,902.70 (net $10,031,902.37) through issuance of 81,000 common shares, pre-funded warrants for 3,107,407 shares, and common warrants for 6,376,814 shares. Recent developments include regaining Nasdaq compliance on April 6, 2026, after a 1-for-3 reverse stock split effective March 10, 2026, reducing outstanding shares from 2,124,772 to 736,127, and full repayment of bridge notes totaling $665,300 principal by early April; however, substantial future share issuances pose dilution risks.

• ·Reverse stock split effective March 10, 2026, reduced authorized common shares from 500,000,000 to 166,666,667 and preferred shares from 69,444 to 23,148.
• ·Nasdaq compliance with Listing Rule 5550(b)(1) ($2,500,000 minimum stockholders’ equity) required by March 30, 2026, and confirmed April 6, 2026; subject to Mandatory Panel Monitor through April 6, 2027.
• ·Common Warrants exercisable for 5.5 years from Initial Registration Statement effective date at $3.20 per share; Placement Agent Warrants at $4.3125 per share.
• ·Company qualifies as smaller reporting company with reduced disclosure obligations.

07-04-2026

KRM Wealth Management L.L.C. filed a 13F-HR report disclosing $182,365,375 in total holdings value across 40 positions as of December 31, 2025. The portfolio is diversified with significant allocations to ETFs, including top holdings such as SCHWAB STRATEGIC TR US LCAP GR ETF ($25,839,886), VANGUARD BD INDEX FDS TOTAL BND MRKT ($25,365,437), SCHWAB STRATEGIC TR US LCAP VA ETF ($23,786,820), and VANGUARD TAX-MANAGED FDS VAN FTSE DEV MKT ($21,382,501). No prior period data is available for comparison.

• ·Filing date: April 07, 2026
• ·Report period end: December 31, 2025
• ·Business address: 3748 Lakeside Dr, Suite 100, Reno, NV 89509
• ·Contact phone: 775-502-8484 or 775-771-9577

07-04-2026

CVD Equipment Corporation completed the sale of its Stainless Design Concepts (SDC) division for a purchase price of approximately $16.9 million in cash, subject to customary adjustments. Net cash proceeds after transaction expenses and taxes are approximately $15.0 million, with $900,000 held in escrow for potential post-closing obligations. The company will retain its Saugerties, New York facility and lease it to the buyer for an initial term of two years, using proceeds to enhance financial flexibility and support strategic initiatives.

• ·Announcement date: April 2, 2026
• ·Filing date: April 07, 2026
• ·Saugerties, New York facility retained and leased to buyer for initial two-year term

07-04-2026

Canadian Derivatives Clearing Corporation (CDCC) filed an 8-K on April 7, 2026, under Item 9.01, attaching Exhibit 99.1, which lists the underlying interests for options listed on the Montreal Exchange and offered for sale in the United States pursuant to its Form S-20 Registration Statement, as of March 31, 2026. The exhibit details equity options on numerous Canadian companies (e.g., 5N Plus Inc., Air Canada, Bank of Montreal), index options (e.g., S&P/TSX 60), options on closed-end funds (e.g., Sprott Physical Gold Trust), Canadian Depositary Receipts (CDRs) for U.S. stocks (e.g., Nvidia CDR, Tesla CDR), and various ETFs (e.g., BMO S&P/TSX Capped Composite Index ETF). No financial performance metrics, changes, or comparisons are reported; this appears to be a routine regulatory update with no notable positive or negative developments.

• ·Filing discloses no changes to prior lists; routine update as of March 31, 2026.
• ·Options offered pursuant to CDCC’s Registration Statement on Form S-20.

07-04-2026

Flywheel Advanced Technology, Inc. dismissed BCRG Group as its independent registered public accounting firm effective April 1, 2026, and simultaneously engaged WSJ And Partners as its new auditor for the quarter ending March 31, 2026, and the fiscal year ending September 30, 2026, with board approval. BCRG's reports for fiscal years ended September 30, 2025, and 2024 were unqualified with no disagreements or reportable events, except for previously disclosed material weaknesses in internal controls. The company provided BCRG a copy of this 8-K, and BCRG's agreeing letter is attached as Exhibit 16.1.

• ·Material weaknesses in internal controls as of September 30, 2025: (i) lack of independent board of directors or audit committee; (ii) no written documentation of internal control policies and procedures; (iii) all financial reporting handled by a financial consultant. Disclosed in Form 10-K filed January 13, 2026.
• ·No consultations with WSJ prior to engagement regarding accounting principles, audit opinions, disagreements, or reportable events.

07-04-2026

KPET Ultra Paceline Corp, a blank check company formerly known as Paceline Solutions Corp, consummated its Initial Public Offering on April 1, 2026, selling 20,000,000 units at $10.00 each for gross proceeds of $200,000,000 held in trust, plus $2,350,000 from 235,000 private placement units. As of April 1, 2026, the audited balance sheet shows total assets of $201,784,765, including $200,000,000 in the Trust Account. However, the company reports a shareholders' deficit of $9,730,611, driven by an accumulated deficit of $9,731,210 from formation and $11,795,810 in transaction costs, including $11,000,000 deferred underwriting fees.

• ·Company incorporated September 29, 2025; name changed to KPET Ultra Paceline Corp on February 27, 2026
• ·Must complete initial Business Combination within 24 months from IPO closing (extendable to 27 months with Sponsor option)
• ·Over-allotment option liability of $158,100; up to 750,000 Class B shares subject to forfeiture if not exercised
• ·Trust Account invested in U.S. government treasury obligations or money market funds
• ·Audited by WithumSmith+Brown, PC (auditor since 2025)

07-04-2026

Orgel Wealth Management, LLC filed its 13F-HR on April 7, 2026, reporting holdings as of March 31, 2026, with a total portfolio value of $4641247588 across 95 positions, all under sole discretionary voting authority. Top holdings include iShares MSCI USA Quality Factor ETF (46432F339) valued at $631568141 with 3292676 shares, iShares Core S&P 500 ETF (464287200) at $398221353 with 609638 shares, and Vanguard Short Term Treasury ETF (92206C102) at $341444598 with 5832672 shares. No period-over-period changes or performance metrics are disclosed in the filing.

• ·All positions reported with sole voting authority (no shared or none).
• ·Business address: 2420 Rivers Edge Drive, Altoona, WI 54720.
• ·Apple Inc (037833100) held at $1983369 with 7815 shares.
• ·Microsoft Corp (594918104) held at $1973007 with 5330 shares.

07-04-2026

Wellgistics Health, Inc. entered into a Note Purchase Agreement dated April 1, 2026, for a private offering of promissory notes with an aggregate principal amount of up to $1,250,000 and an aggregate purchase price of $1,000,000. The agreement involves Dawson James Securities, Inc. as Placement Agent and is subject to closing conditions including representations, warranties, and delivery of executed documents. No financial performance metrics or period-over-period comparisons are provided in the filing.

• ·Agreement closing to occur remotely via exchange of documents on or around April 1, 2026.
• ·Notes subject to Nasdaq rules limiting Common Stock issuance without stockholder approval.
• ·Company represents no outstanding Indebtedness except as disclosed on Schedule 7.4 and no Liens except as on Schedule 7.5.

07-04-2026

Xcel Energy Inc. filed a Definitive Additional Proxy Statement (DEFA14A) notice for its 2026 Annual Meeting on May 20, 2026, at 12:00 p.m. Central Time, held virtually at www.virtualshareholdermeeting.com/XEL2026. Shareholders can vote on the election of 10 director nominees (Megan Burkhart, Lynn Casey, Maria Demaree, Bob Frenzel, Netha Johnson, Patricia Kampling, George Kehl, Charles Pardee, Devin Stockfish, and Timothy Welsh), an advisory 'say-on-pay' vote on executive compensation, and ratification of Deloitte & Touche LLP as the independent registered public accounting firm for 2026, with the board recommending 'FOR' all items. Voting must be completed by May 19, 2026, 11:59 p.m. ET.

• ·Proxy materials available online at www.ProxyVote.com; paper/email copies requestable by May 6, 2026 via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com (include control number)
• ·Company address: 414 Nicollet Mall, Minneapolis, MN 55401, Attn: Investor Relations
• ·Filing date: April 07, 2026; no fee required

07-04-2026

KraneShares Trust issued Definitive Additional Materials (DEFA14A) on April 7, 2026, as a follow-up to a prior Proxy Statement, urging shareholders to provide input on a time-sensitive matter. The letter, dated April 13, 2026, notes unsuccessful prior contact attempts via mail, email, and phone, and directs shareholders to call Broadridge Financial Solutions, Inc. at 1-888-331-7160 (weekdays, 9:00 a.m. to 10:00 p.m. ET) to respond promptly. No financial or performance data is disclosed.

• ·Address: 280 Park Avenue, 32nd Floor, New York, NY 10017

07-04-2026

CareCloud, Inc. issued a DEFA14A filing as notice for its Annual Meeting of Shareholders on June 4, 2026, at 11:00 a.m. ET, to elect board nominees Mahmud Haq and Cameron Munter, approve on an advisory basis the compensation of named executive officers, approve the 2026 Equity Incentive Plan, and ratify Tanner LLP as independent auditors for the year ending December 31, 2026. The record date is April 7, 2026, with proxies due by midnight on May 29, 2026; shareholders can vote online at www.vstocktransfer.com/proxy using their 12-digit control number or request paper copies.

• ·Meeting location: 7 Clyde Road, Somerset, NJ 08873.
• ·Notice of Internet Availability to be mailed on or about April 15, 2026.
• ·Proxy materials available at https://ir.carecloud.com/sec-filings.

07-04-2026

Twele Capital Management, Inc. disclosed its Q1 2026 13F-HR holdings as of March 31, 2026, totaling $560,857,163 across 39 positions primarily consisting of iShares, Vanguard, and Schwab ETFs focused on equities, bonds, and international markets. Top holdings include iShares Core S&P 500 ETF at $64,068,220, Vanguard S&P 500 ETF at $59,020,014, Vanguard Total Bond Market ETF at $55,119,467, iShares 7-10 Year Treasury Bond ETF at $47,439,884, and iShares Core U.S. Aggregate Bond ETF at $47,185,712. The portfolio reflects a diversified, passive investment approach with significant fixed income exposure.

• ·Filed on April 07, 2026
• ·Period end: March 31, 2026
• ·State of incorporation: MN
• ·Business address: 5601 Smetana Drive, Suite 707, Minnetonka, MN 55343

07-04-2026

Ellington Financial Inc. announced on April 7, 2026, that its Board of Directors declared a monthly dividend of $0.13 per share on common stock, payable on May 29, 2026, to stockholders of record as of April 30, 2026. The press release is filed as Exhibit 99.1.

• ·Securities registered on NYSE: Common Stock (EFC), Series B Preferred (EFC PR B), Series C Preferred (EFC PR C), Series D Preferred (EFC PRD)
• ·Company address: 53 Forest Avenue, Old Greenwich, CT 06870

07-04-2026

Thermo Fisher Scientific Inc. (TMO) filed a Definitive Additional Proxy Statement (DEFA14A) on April 07, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee is required and is marked as Definitive Additional Materials. No substantive proxy details, financial metrics, or changes are disclosed in the provided document header.

07-04-2026

Transportation and Logistics Systems, Inc. (TLSS) entered into a Member Interest and Asset Exchange Agreement on April 1, 2026, for a reverse triangular merger to acquire 80% membership interest in Patriot Glass Solutions, LLC (PGS) and four nanotechnology patents from Badcer Ops, Inc. for $4,750,000 payable in 47,500 shares of Series J Senior Convertible Preferred Stock. PGS provides window tinting and C-Bond glass strengthening solutions through a network of more than 50 dealers, aligning with TLSS's strategy to expand in safety and security technology. Closing is expected by June 1, 2026, subject to due diligence, financial statements, and other conditions; no financial performance data or comparisons were provided.

• ·Michael Wanke to enter employment agreement with PGS as closing condition
• ·Closing conditions include audited PGS financials for year-end 2024 and 2025, unaudited Q1 2026 financials, due diligence, landlord consent for lease assignment
• ·Seller shareholders: Jeff Badders and Mercer Street Global Opportunity Fund, LLC (existing TLSS preferred stockholder)

07-04-2026

Wheeler Real Estate Investment Trust, Inc. processed five redemption requests for 5,200 shares of Series D Cumulative Convertible Preferred Stock on April 6, 2026, at approximately $41.28 per share (including $25.00 principal plus accrued dividends), settling the aggregate redemption price through issuance of 207,066 shares of Common Stock. The lowest conversion price for these redemptions was approximately $1.04, triggering an adjustment to the conversion price of the 7.00% Subordinated Convertible Notes due 2031 to approximately $0.57 per share (43.85 shares per $25 principal), representing a 45% discount. Cumulatively, 1,782,283 Series D shares have been redeemed via 407 requests, with approximately 600,000 Common Stock shares issued in settlement, leaving 1,813,124 Common shares and 1,715,095 Series D shares outstanding as of April 6, 2026.

• ·31st monthly Holder Redemption Date: April 6, 2026
• ·Deadline for May 2026 Series D redemptions: April 27, 2026
• ·Next Holder Redemption Date: May 5, 2026
• ·Redemption forms and FAQs available at https://ir.whlr.us/series-d/series-d-redemption

07-04-2026

CCC Intelligent Solutions Holdings Inc.'s 2025 Proxy Statement details FY 2025 executive compensation, with CEO Githesh Ramamurthy's total pay at $987,736, up 4% from $946,288 in FY 2024, while CFO Brian Herb's total remained essentially flat at $4,116,185 versus $4,096,863. Other NEOs received substantial stock awards, such as $5.4M to President Tim Welsh, but EVP Mary Jo Prigge retired on June 6, 2025, receiving $2.87M in separation benefits, and EVP John Goodson resigned on October 10, 2025, forfeiting approximately $6.7M in unvested stock awards across 2023-2025. The company adopted a compliant Clawback Policy and enhanced 401(k) matching to 8% of salary effective July 1, 2024.

• ·Clawback Policy requires recovery of excess incentive-based compensation from covered executives over three completed fiscal years preceding any restatement, applicable to awards received after Nasdaq Listing Rule 5608 effective date.
• ·All NEOs subject to employment agreements with base salaries, AIP eligibility, severance, and restrictive covenants.
• ·Executive perks include financial planning via Goldman Sachs Ayco and executive physicals via MDVIP.
• ·John Goodson forfeited stock awards valued at $2,192,820 (2023), $2,100,010 (2024), and $2,400,005 (2025) upon resignation October 10, 2025.
• ·Mary Jo Prigge separation includes COBRA coverage through December 31, 2025 valued at approximately $3,226.

07-04-2026

Paramount Skydance Corporation filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, authorizing a total of 7,155,000,000 shares of capital stock: 55,000,000 shares of Class A Common Stock ($0.001 par value), 7,000,000,000 shares of Class B Common Stock ($0.001 par value), and 100,000,000 shares of Preferred Stock ($0.001 par value). The amendment also revises dividend provisions under Section 2(b) of Article IV, providing flexibility for dividends to Class B holders (with Class A consent) while maintaining ratable treatment for other distributions. The amendment was adopted pursuant to Delaware General Corporation Law Sections 242 and 228 and signed by Secretary Stephanie K. McKinnon on April 7, 2026.

07-04-2026

Bankwell Financial Group, Inc. filed a DEFA14A Definitive Additional Materials proxy statement on April 07, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing, marked as non-preliminary and non-confidential, was submitted by the registrant with no fee required. No specific proposals, financial data, or shareholder actions are detailed in the provided filing header.

07-04-2026

ABLES, IANNONE, MOORE & ASSOCIATES, INC. filed a 13F-HR report disclosing total holdings of $168,120,518 across 59 positions as of March 31, 2026. Top positions include Apple Inc. ($23,636,293), NVIDIA Corporation ($19,551,810), and Amazon.com Inc. ($14,694,073). No prior period data or changes are provided in this filing.

• ·Filing submitted on April 07, 2026, for period ending March 31, 2026.
• ·All holdings reported as sole voting authority with no shared or discretionary authority indicated.

07-04-2026

Coca-Cola Europacific Partners plc (CCEP) disclosed details of its ordinary share repurchases under its buyback program, purchasing a total of 290,898 shares between March 30 and April 2, 2026, across US Trading Venues (200,000 shares), London Stock Exchange, and CBOE Europe Limited (CXE) (90,898 shares). USD transactions had highest prices up to $92.9100, lowest $89.7700, and VWAPs ranging $90.7602-$92.3213 per share. GBP transactions showed highest £70.0000, lowest £67.7000, and VWAPs £68.4441-£69.4364 per share.

• ·30 March 2026: 50,000 shares at USD 91.2400 VWAP (US); 41,898 at GBP 69.4364 VWAP (LSE); 3,000 at GBP 69.4238 VWAP (CXE)
• ·31 March 2026: 50,000 shares at USD 90.7602 VWAP (US); 38,000 at GBP 69.1927 VWAP (LSE); 3,000 at GBP 69.2751 VWAP (CXE)
• ·1 April 2026: 50,000 shares at USD 91.3374 VWAP (US); 4,000 at GBP 68.4495 VWAP (LSE); 1,000 at GBP 68.4441 VWAP (CXE)
• ·2 April 2026: 50,000 shares at USD 92.3213 VWAP (US)

07-04-2026

J.P. Morgan Real Estate Income Trust, Inc. issued Class E, Class I, and Class Y shares of common stock on March 2, 2026, and April 1, 2026, through its distribution reinvestment plan (DRIP) and private placements to accredited investors, raising $1.65 million, $11.45 million, $1.67 million, and $54.68 million in aggregate purchase prices, respectively. The transactions were exempt from Securities Act registration under Section 4(a)(2) and Regulation D. Aggregate commissions paid in connection with Class Y share sales totaled $0.19 million.

• ·Share prices: Class E $11.40 (March 2), $11.44 (April 1); Class I $10.58 (March 2), $10.61 (April 1); Class Y $11.22 (DRIP March 2), $11.41 (private March 2), $11.25 (DRIP April 1), $11.46 (private April 1)
• ·Transactions exempt under Section 4(a)(2) of Securities Act and Regulation D; no public offering or general solicitation
• ·Registrant is an emerging growth company

07-04-2026

Federal Home Loan Bank of Chicago reported under Item 2.03 the creation of a direct financial obligation via a consolidated obligation bond for which it is the primary obligor, with a par value of $30,000,000. The bond features a fixed constant coupon rate of 3.873%, matures on April 7, 2027, and has an optional principal redemption (Bermudan style) with next call date July 7, 2026. This issuance is part of routine funding through capital markets sales of consolidated obligations, which are joint obligations of the eleven Federal Home Loan Banks.

• ·Trade date: April 2, 2026
• ·Settlement date: April 7, 2026
• ·Next pay date: October 7, 2026
• ·Next call date: July 7, 2026
• ·Call type: Optional Principal Redemption
• ·Call style: Bermudan
• ·Rate type/rate sub-type: Fixed Constant
• ·CUSIP: 3130BAAK3

07-04-2026

The Trustee's Report for Select Notes Trust LT 2004-1 details the April 1, 2026 Interest Distribution Date, with $101,250.00 in interest received solely from General Elec Cap Co 6.750% notes, while all other underlying securities paid $0.00 in interest and principal. Total interest distributed to certificateholders was $151,959.05, supported by advances of $61,333.00, resulting in net advances owed of $464,892.50 and interest expense to the advancing party of $10,627.50. The trust's principal balance stands at $28,980,000.00 with 31,980 certificates outstanding.

• ·Per certificate interest income for Form 1099: $3.166041
• ·Per certificate interest expense for Form 1099 footnote: $0.332317
• ·No principal payments from any underlying securities during the period
• ·Interest Period: day after March 1, 2026 to April 1, 2026

07-04-2026

Claris Financial LLC filed its 13F-HR on April 7, 2026, reporting holdings as of September 30, 2025, with a total portfolio value of $176,119,949 across 170 positions, heavily weighted toward ETFs and large-cap stocks. Top holdings include First Trust Value Dividend Index ETF ($11,300,241), Vanguard Growth ETF ($10,261,783), Apple Inc. ($8,941,036), and NVIDIA Corp. ($7,966,788). The portfolio shows diversification but includes one position with zero market value (Global Aircraft Solutions, 613,000 shares).

• ·Filing period end date: September 30, 2025
• ·Business address: 4510 Cox Rd Suite 302, Glen Allen, VA 23060
• ·One holding (Global Aircraft Solutions) has 613,000 shares but $0 market value due to SEC registration revocation effective 12/05/11

07-04-2026

Bulwark Capital Corp filed its 13F-HR on April 07, 2026, reporting holdings as of March 31, 2026, consisting of numerous ETFs and stocks held solely with full voting authority matching share counts. The portfolio is dominated by fixed income and Treasury-related ETFs, including PGIM Ultra Short Bond ETF at $15.93B (321880 shares) and JPMorgan Limited Duration Bond ETF at $12.33B (236214 shares). Individual stock holdings like Amazon.com Inc at $20.8M (100 shares) and Microsoft Corp at $145.8M (394 shares) represent smaller allocations.

• ·All holdings reported as SOLE ownership with matching sole voting authority and zeros in shared/other columns
• ·Filer CIK: 0002075899, SEC file number: 028-25649
• ·Business address: 10 Crane Island Dr, Fernandina Beach, FL 32034

07-04-2026

Blueline Advisors LLC filed its 13F-HR on April 7, 2026, disclosing equity holdings as of March 31, 2026, totaling $128,953,024 across 217 positions, all held with sole voting and investment power and no shared power reported. Largest positions include Vanguard Index Fds Value ETF ($18,116,872), Vanguard Index Fds Growth ETF ($14,293,395), and SSGA Active ETF Tr State Street BLA ($6,040,316). The portfolio is heavily weighted toward ETFs, with no changes or amendments indicated.

• ·Holdings concentrated in ETFs (e.g., iShares, Vanguard, Invesco, SPDR series) and individual stocks like Apple Inc (1,301 shares, $330,181), NVIDIA Corporation (1,200 shares, $209,280), and AT&T Inc (1,028 shares, $29,802).
• ·Several positions report 0 shares (e.g., Invesco Exch Traded Fd Tr II Emrng Mkt Sv rg, iShares Inc Em Mkts Div ETF).
• ·Filer based in Exeter, NH, with CIK 0002110066.

07-04-2026

PGIM Private Credit Fund filed an 8-K on April 7, 2026, including Exhibit 3.1, the Fifth Amended and Restated Agreement and Declaration of Trust effective April 1, 2026, which fully restates the prior Fourth Amended and Restated version dated June 27, 2025. The document establishes the fund as a Delaware statutory trust, outlines its name and business conduct, and defines key terms such as Adviser, Affiliate, Cash Flow, and Common Shares. No financial metrics, performance changes, or operational impacts are disclosed.

• ·Prior amendments: Fourth A&R Declaration dated June 27, 2025; Third A&R dated July 12, 2024; Second A&R dated March 22, 2024; A&R Declaration dated September 29, 2022; Original Agreement dated March 21, 2022, amended June 21, 2022.
• ·Governed by Delaware Statutory Trust Act; references 1940 Act, ERISA, Securities Act, Exchange Act.

07-04-2026

Federal Home Loan Bank of Des Moines filed an 8-K disclosing new consolidated obligations (callable bonds) issued in early April 2026 with a total par value of $622 million. The issuances include both fixed-rate (rates 4.10%-4.60%) and variable-rate bonds, primarily Bermudan or American style with optional principal redemption, maturing between 2026 and 2031. No prior period comparisons are provided in the filing.

• ·Trade dates: April 1-2, 2026; Settlement dates: April 6-28, 2026
• ·Maturity dates range from July 6, 2026 to April 28, 2031
• ·Call dates start from October 6, 2026; Largest single CUSIP group: 3130BA7D3 ($475M total, variable single index floater)
• ·Fixed-rate examples: 4.251% (3130BA6S1), 4.38% (3130BAAE7), 4.60% (3130BAAF4); Variable: 3130BA7D3 (N/A coupon)

07-04-2026

Teladoc Health's DEF 14A Proxy Statement for the 2026 Annual Meeting on May 21, 2026 (record date March 26, 2026) seeks stockholder approval for electing nine directors, an advisory vote on executive compensation, and ratification of Ernst & Young LLP as auditors for fiscal 2026. 2025 performance highlights include total revenue of $2.5B, adjusted EBITDA of $281M (11.1% margin), cash and equivalents of $781M, international revenue of $458M (up 12%), and U.S. integrated care members of 101.8M (up 9%). No declines or flat metrics are noted in the filing excerpt.

• ·Virtual annual meeting at www.virtualshareholdermeeting.com/TDOC2026 on May 21, 2026 at 2:00 p.m. EDT; requires 16-digit control number.
• ·Board recommends 'FOR' all three proposals: director elections (page 8), say-on-pay (page 27), auditor ratification (page 67).
• ·Filing includes executive compensation discussion, pay vs. performance data, and director compensation details.